Samenvatting
Anti-tuberculosis (TB) drugs can cause adverse drug reactions, particularly the older second-line drugs. Early intervention and adequate management of adverse drug reactions are important to prevent complications. Laboratory testing at baseline and during treatment, in addition to clinical monitoring, is protocolized to improve patient and treatment management. This chapter provides an overview of the most frequent and severe adverse effects caused by the first-and second-line drugs used for the treatment of tuberculosis. An approach on how to manage the adverse drugs effects is briefly described.
Originele taal-2 | English |
---|---|
Titel | Essential Tuberculosis |
Uitgeverij | Springer International Publishing AG |
Hoofdstuk | 13 |
Pagina's | 121-129 |
Aantal pagina's | 9 |
ISBN van elektronische versie | 9783030667030 |
ISBN van geprinte versie | 9783030667054 |
DOI's | |
Status | Published - 1-jan.-2021 |